Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Recurrent Sex Cord-Stromal Tumors of the Ovary
NCT00748657Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2008
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Ovarian sex-cord stromal tumor (SCST), sponsored by National Cancer Institute. Started Sep 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
Ovarian sex-cord stromal tumor (SCST)
Beyond the preview
Go deeper on NCT00748657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748657.